Hospital de Jolimont Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01428973
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pôle Hospitalier Jolimont